{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T22:50:04Z","timestamp":1792450204705,"version":"4.5.0"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T00:00:00Z","timestamp":1786406400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004000","name":"Guangzhou Municipal Science and Technology Program key projects","doi-asserted-by":"publisher","award":["2025A03J3218"],"award-info":[{"award-number":["2025A03J3218"]}],"id":[{"id":"10.13039\/501100004000","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.bcp.2026.118328","type":"journal-article","created":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T15:01:46Z","timestamp":1786114906000},"page":"118328","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"P2","title":["Identification of CLIC1 as a direct molecular target of luteolin associated with ferroptosis induction in hepatocellular carcinoma"],"prefix":"10.1016","volume":"253","author":[{"given":"Yue","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4914-5131","authenticated-orcid":false,"given":"Han","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fengxiang","family":"Pang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-9319-0511","authenticated-orcid":false,"given":"Yali","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongjie","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.bcp.2026.118328_b0005","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1038\/s41575-024-01021-z","article-title":"Current and emerging strategies for the prevention of hepatocellular carcinoma","volume":"22","author":"Yeo","year":"2025","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"issue":"10","key":"10.1016\/j.bcp.2026.118328_b0010","article-title":"Computed tomography for the diagnosis of hepatocellular carcinoma in adults with chronic liver disease","volume":"10","author":"Nadarevic","year":"2021","journal-title":"Cochrane Database Syst. Rev."},{"issue":"6","key":"10.1016\/j.bcp.2026.118328_b0015","doi-asserted-by":"crossref","first-page":"495","DOI":"10.5582\/bst.2024.01423","article-title":"Expert consensus on sequential surgery after immune-targeted conversion therapy for advanced hepatocellular carcinoma in China","volume":"18","author":"Song","year":"2024","journal-title":"Biosci. Trends"},{"key":"10.1016\/j.bcp.2026.118328_b0020","article-title":"Progress of immune checkpoint inhibitors in the treatment of advanced hepatocellular carcinoma","volume":"15","author":"Liu","year":"2024","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bcp.2026.118328_b0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.bios.2022.113982","article-title":"An automated and mobile magnetoresistive biosensor system for early hepatocellular carcinoma diagnosis","volume":"202","author":"Yao","year":"2022","journal-title":"Biosens. Bioelectron."},{"issue":"1","key":"10.1016\/j.bcp.2026.118328_b0030","article-title":"Synergistic strategies in systemic therapy for advanced hepatocellular carcinoma","volume":"10","author":"Yu","year":"2026","journal-title":"Glob Chall"},{"key":"10.1016\/j.bcp.2026.118328_b0035","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.783236","article-title":"Strategies to improve the antitumor effect of immunotherapy for hepatocellular carcinoma","volume":"12","author":"Xing","year":"2021","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.bcp.2026.118328_b0040","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1186\/s12943-024-02101-z","article-title":"Biomarkers for diagnosis and therapeutic options in hepatocellular carcinoma","volume":"23","author":"Chan","year":"2024","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.bcp.2026.118328_b0045","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.642958","article-title":"Tumor-intrinsic mechanisms regulating immune exclusion in liver cancers","volume":"12","author":"Lindblad","year":"2021","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.bcp.2026.118328_b0050","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1038\/s41420-024-02195-w","article-title":"Mechanisms of ferroptosis and targeted therapeutic approaches in urological malignancies","volume":"10","author":"Ma","year":"2024","journal-title":"Cell Death Discov"},{"issue":"1","key":"10.1016\/j.bcp.2026.118328_b0055","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1186\/s12951-021-01102-0","article-title":"Self-amplification of oxidative stress with tumour microenvironment-activatable iron-doped nanoplatform for targeting hepatocellular carcinoma synergistic cascade therapy and diagnosis","volume":"19","author":"Zhou","year":"2021","journal-title":"J. Nanobiotechnol."},{"issue":"2","key":"10.1016\/j.bcp.2026.118328_b0060","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1038\/s41416-022-01998-x","article-title":"Ferroptosis in hepatocellular carcinoma: mechanisms and targeted therapy","volume":"128","author":"Ajoolabady","year":"2023","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.bcp.2026.118328_b0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2024.117769","article-title":"Ferroptosis in hepatocellular carcinoma: mechanisms and therapeutic implications","volume":"182","author":"Tu","year":"2025","journal-title":"Biomed. Pharmacother."},{"issue":"9","key":"10.1016\/j.bcp.2026.118328_b0070","doi-asserted-by":"crossref","first-page":"3621","DOI":"10.7150\/ijbs.96014","article-title":"Current progress of ferroptosis study in hepatocellular carcinoma","volume":"20","author":"Zhu","year":"2024","journal-title":"Int. J. Biol. Sci."},{"issue":"1","key":"10.1016\/j.bcp.2026.118328_b0075","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1038\/s41420-024-01863-1","article-title":"Ferroptosis: a new hunter of hepatocellular carcinoma","volume":"10","author":"Jiang","year":"2024","journal-title":"Cell Death Discov."},{"issue":"7","key":"10.1016\/j.bcp.2026.118328_b0080","doi-asserted-by":"crossref","first-page":"3417","DOI":"10.1002\/ptr.8217","article-title":"Luteolin: a promising multifunctional natural flavonoid for human diseases","volume":"38","author":"Zhu","year":"2024","journal-title":"Phytother. Res."},{"key":"10.1016\/j.bcp.2026.118328_b0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2024.116909","article-title":"Luteolin as a potential therapeutic candidate for lung cancer: emerging preclinical evidence","volume":"176","author":"Zhang","year":"2024","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.bcp.2026.118328_b0090","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/1987588","article-title":"Paving luteolin therapeutic potentialities and agro-food-pharma applications: emphasis on in vivo pharmacological effects and bioavailability traits","volume":"2021","author":"Taheri","year":"2021","journal-title":"Oxid. Med. Cell. Longev."},{"key":"10.1016\/j.bcp.2026.118328_b0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2022.115044","article-title":"Luteolin binds Src, promotes STAT3 protein ubiquitination and exerts anti-melanoma effects in cell and mouse models","volume":"200","author":"Li","year":"2022","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bcp.2026.118328_b0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2026.121326","article-title":"Luteolin, a bioactive compound from Celastrus orbiculatus stem, inhibits cervical cancer via CA2 suppression: A translational study bridging basic research and clinical application","volume":"362","author":"Chen","year":"2026","journal-title":"J. Ethnopharmacol."},{"issue":"3","key":"10.1016\/j.bcp.2026.118328_b0105","doi-asserted-by":"crossref","DOI":"10.3892\/ijmm.2024.5401","article-title":"Luteolin enhances drug chemosensitivity by downregulating the FAK\/PI3K\/AKT pathway in paclitaxel\u2011resistant esophageal squamous cell carcinoma","volume":"54","author":"Yang","year":"2024","journal-title":"Int. J. Mol. Med."},{"issue":"2","key":"10.1016\/j.bcp.2026.118328_b0110","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1002\/ptr.8066","article-title":"Luteolin, a flavone ingredient: Anticancer mechanisms, combined medication strategy, pharmacokinetics, clinical trials, and pharmaceutical researches","volume":"38","author":"Shi","year":"2024","journal-title":"Phytother. Res."},{"issue":"8","key":"10.1016\/j.bcp.2026.118328_b0115","first-page":"3300","article-title":"Intracellular chloride channel 1 and tumor","volume":"13","author":"Zhang","year":"2023","journal-title":"Am. J. Cancer Res."},{"issue":"Pt 4","key":"10.1016\/j.bcp.2026.118328_b0120","article-title":"CLIC1 regulates cellular oxidative stress and gastric cancer progress by enhancing ACOX1 ubiquitination","volume":"330","author":"Li","year":"2025","journal-title":"Int. J. Biol. Macromol."},{"issue":"30","key":"10.1016\/j.bcp.2026.118328_b0125","doi-asserted-by":"crossref","first-page":"10659","DOI":"10.1021\/acs.analchem.2c00903","article-title":"Probing iron-mediated synergistic change of Cl(-) and HClO in liver cancer cells with a dual-color fluorescence reporter","volume":"94","author":"Fan","year":"2022","journal-title":"Anal. Chem."},{"issue":"1","key":"10.1016\/j.bcp.2026.118328_b0130","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/s13046-021-02213-0","article-title":"Chloride intracellular channel 1 activity is not required for glioblastoma development but its inhibition dictates glioma stem cell responsivity to novel biguanide derivatives","volume":"41","author":"Barbieri","year":"2022","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"02","key":"10.1016\/j.bcp.2026.118328_b0135","first-page":"259","article-title":"Luteolin combined with entecavir inhibits hepatitis B virus replication by regulating the Keap1\/Nrf2\/ARE signaling pathway","volume":"26","author":"Luo","year":"2026","journal-title":"China Trop. Med."},{"key":"10.1016\/j.bcp.2026.118328_b0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2025.156799","article-title":"Luteolin alleviates estrogen deficiency-induced muscle atrophy via targeting SLC7A11-mediated ferroptosis","volume":"142","author":"Liu","year":"2025","journal-title":"Phytomedicine"},{"issue":"4","key":"10.1016\/j.bcp.2026.118328_b0145","article-title":"Luteolin synergistically enhances antitumor activity of oxaliplatin in colorectal carcinoma via AMPK inhibition","volume":"11","author":"Jang","year":"2022","journal-title":"Antioxidants (Basel)"},{"issue":"4","key":"10.1016\/j.bcp.2026.118328_b0150","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1002\/hep.32741","article-title":"Attacking the public health crisis of hepatocellular carcinoma at its roots","volume":"77","author":"Lee","year":"2023","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.bcp.2026.118328_b0155","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/s41420-024-02037-9","article-title":"Ferroptosis: a double-edged sword","volume":"10","author":"Wang","year":"2024","journal-title":"Cell Death Discov"},{"key":"10.1016\/j.bcp.2026.118328_b0160","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2024.103211","article-title":"Ferroptosis in health and disease","volume":"75","author":"Berndt","year":"2024","journal-title":"Redox Biol."},{"key":"10.1016\/j.bcp.2026.118328_b0165","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2024.116512","article-title":"GPX4, ferroptosis, and diseases","volume":"174","author":"Zhang","year":"2024","journal-title":"Biomed. Pharmacother."},{"issue":"4","key":"10.1016\/j.bcp.2026.118328_b0170","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1016\/j.ncrna.2024.05.007","article-title":"Non-coding RNA: a key regulator in the glutathione-GPX4 pathway of ferroptosis","volume":"9","author":"Hussain","year":"2024","journal-title":"Noncoding RNA Res"},{"key":"10.1016\/j.bcp.2026.118328_b0175","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.freeradbiomed.2025.07.045","article-title":"Systemic aldehyde storm induced by allyl alcohol exposure results in extensive hepatic ferroptosis in Aldh2\u22172 knock-in mice","volume":"239","author":"Takami","year":"2025","journal-title":"Free Radic. Biol. Med."},{"issue":"22","key":"10.1016\/j.bcp.2026.118328_b0180","doi-asserted-by":"crossref","DOI":"10.3390\/cells14221800","article-title":"Ferroptosis in anaplastic thyroid cancer: molecular mechanisms, preclinical evidence, and therapeutic prospects","volume":"14","author":"Lee","year":"2025","journal-title":"Cells"},{"key":"10.1016\/j.bcp.2026.118328_b0185","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1555518","article-title":"The role of non-coding RNA in ferroptosis of liver cancer and its impact on lipid peroxidation","volume":"16","author":"Ding","year":"2025","journal-title":"Front. Immunol."}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295226006672?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295226006672?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T20:12:57Z","timestamp":1788811977000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295226006672"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":37,"alternative-id":["S0006295226006672"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2026.118328","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Identification of CLIC1 as a direct molecular target of luteolin associated with ferroptosis induction in hepatocellular carcinoma","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2026.118328","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"118328"}}